BARCLAYS PLC

Position in ETON — Eton Pharmaceuticals, Inc.

CIK 312069 LONDON, X0

Position in ETON

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,033,752

+$815,203 QoQ

Shares Held

56,181

+13.8% QoQ

Ownership

0.197%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#47

of 163 holders

Holding Since

Jun 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

BARCLAYS PLC holds $487,957,812 across 61 Drug Manufacturers - Specialty & Generic names. ETON ranks #17 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	2,302,737	$165,474,680
2	NBIX	Neurocrine Biosciences Inc	324,807	$54,742,970
3	TEVA	Teva Pharmaceutical Industries Ltd	1,343,554	$45,519,608
4	UTHR	UNITED THERAPEUTICS Corp	72,010	$39,017,177
5	VTRS	Viatris Inc	2,437,004	$38,699,622
6	INDV	Indivior Pharmaceuticals, Inc.	907,024	$37,215,193
7	HIMS	Hims & Hers Health, Inc.	861,006	$29,851,076
8	ALKS	Alkermes plc.	219,935	$11,524,592

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,033,752	56,181	+13.8%	Shares	Defined	2026-08-14
2026-03-31	$1,218,549	49,374	-4.0%	Shares	Defined	2026-05-15
2025-12-31	$869,985	51,448	+39.8%	Shares	Sole	2026-02-13
2025-09-30	$799,793	36,806	-19.6%	Shares	Sole	2026-03-31
2025-06-30	$652,507	45,790	+2.5%	Shares	Sole	2026-02-27
2025-03-31	$579,699	44,661	-18.6%	Shares	Sole	2026-03-17
2024-12-31	$731,081	54,886	+2468.4%	Shares	Sole	2026-03-19
2021-09-30	$10,770	2,137	-46.4%	Shares	Sole	2021-11-09
2021-06-30	$24,577	3,990	-72.1%	Shares	Sole	2021-08-13
2021-03-31	$104,514	14,278	+159.1%	Shares	Sole	2021-05-13
2020-12-31	$44,804	5,511	-18.0%	Shares	Sole	2021-02-11
2020-09-30	$53,088	6,720	-16.7%	Shares	Sole	2020-11-12
2020-06-30	$43,948	8,064	—	Shares	Sole	2020-08-12
No filing history on record for this holder in this stock.